missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. CLEC4D/CLECSF8 Rabbit anti-Human, Clone: 1, Novus Biologicals™
  7. 18257957

CLEC4D/CLECSF8 Rabbit anti-Human, Clone: 1, Novus Biologicals™

Rabbit Monoclonal Antibody

Brand:  Novus Biologicals NBP2-89905-50UL

 View more versions of this product

Product Code. 18257957

  • £286.00 / 50µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CLEC4D/CLECSF8 Monoclonal specifically detects CLEC4D/CLECSF8 in Human samples. It is validated for ELISA.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CLEC4D/CLECSF8
Monoclonal
Unconjugated
0.2 um filtered solution in PBS
Rabbit
Protein A purified
RUO
338339
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
IgG
ELISA
1
ELISA 1:5000-1:10000
CLEC6, CLEC-6, CLECSF8Mpcl, C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamilymember 8, C-type lectin domain family 4 member D, C-type lectin domain family 4, member D, C-type lectin receptor, C-type lectin superfamily member 8, C-type lectin-like receptor 6, macrophage C-type lectin, MCL, MGC40078, MPCL
Recombinant Human CLEC4D/CLECSF8 Protein
50 μg
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.